Computer-aided quantification of retinal neovascularization
暂无分享,去创建一个
A. Stahl | L. Smith | K. Connor | N. Krah | R. J. Dennison | K. Guerin | P. Sapieha | K. Willett | J. Chen | A. Stahl | K. M. Connor | P. Sapieha | K. L. Willett | N. M. Krah | J. Chen | K. I. Guerin | L. E. H. Smith | Jing Chen | J. Chen | Andreas Stahl | Jing Chen | Lois E. H. Smith
[1] P. Carmeliet,et al. Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration , 2009, Pediatric Research.
[2] Lois E. H. Smith,et al. Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.
[3] Lois E. H. Smith,et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] K. Yu,et al. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. , 1999, Current eye research.
[5] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[6] Martin Friedlander,et al. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. , 2006, Investigative ophthalmology & visual science.
[7] Lois E. H. Smith,et al. Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.
[8] R. Ali,et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1 , 2002, Gene Therapy.
[9] Paolo Valerio,et al. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. , 2006, Current medicinal chemistry.
[10] H. Shapiro,et al. Ranibizumab for Neovascular Age-Related Macular Degeneration (AMD): Optical Coherence Tomography (OCT) vs. Visual Acuity (VA) Changes in PIER Study , 2008 .
[11] Philip J Rosenfeld,et al. Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[12] Lois E. H. Smith,et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.
[13] H. Suzuki,et al. Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. , 1999, Life sciences.
[14] P. Campochiaro,et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. , 2000, The American journal of pathology.
[15] M. Capogrossi,et al. Marked inhibition of retinal neovascularization in rats following soluble‐flt‐1 gene transfer , 2004, The journal of gene medicine.
[16] Donald Kennedy,et al. Breakthrough of the Year , 2007, Science.
[17] G. Haddad,et al. Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression , 2009, Proceedings of the National Academy of Sciences.
[18] D Kennedy,et al. Breakthrough of the Year , 2003, Science.
[19] S. Pri-chen,et al. An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice , 2005, Eye.
[20] Lois E. H. Smith,et al. Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.